October 15, 2018

Infectious Diarrhea Spores Survive High Temperatures of Hospital Laundering 

October 16, 2018 [Science Daily] “Washing contaminated hospital bedsheets in a commercial washing machine with industrial detergent at high disinfecting temperatures failed to remove all traces of Clostridium difficile (C. difficile), a bacteria that causes infectious diarrhea, suggesting that linens could be a source of infection among patients and even other hospitals, according to a new study. Read full story here

WhatsApp Alert Improves Real-Time Antimicrobial Stewardship Program

October 11, 2018 [Healio] “A hospital antimicrobial stewardship program in Mexico City incorporated a smartphone messaging app as a fundamental part of real-time surveillance, improving the appropriate use of antibiotics, decreasing bacterial resistance and saving money.” Read full article here 

Increasing Duration of Surgical Prophylaxis Does Not Decrease Odds of SSI

October 5, 2018 [ConatgionLive] “Surgical site infections are among the most common causes of healthcare-associated infections, and the human and financial costs of treating them continue to increase” Recent study shows C. diff and antimicrobial duration are interrelated “there was a 7% increase in odds for 24 to less than 48 hours. The odds then went up to 140% for 48 to 72 hours, and then 265% for greater than 72 hours…There was also an impact of antimicrobial choice on the rates of post-operative C diff infections, and this was predominately driven by clindamycin and fluoroquinolones.” Read more here

Ecolab Gains EPA-registered Disinfectant Claim Against Clostridium Difficile

October 4, 2018 [Cleanroom Teachnology] Ecolab has announced that the US Environmental Protection Agency has granted laundry disinfectant claim against Clostridium difficile to its AdvaCare product. Read more here

New C. diff Drug to be Tested on Patients for First Time

September 13, 2018 [BBC News] “Glasgow-based life sciences firm MGB Biopharma (MGB) said it is preparing to launch a Phase II clinical trial of its anti-bacterial agent MGB-BP-3. The trial is expected to involve 30 patients based in North America.” Read more here

SHEA Panel Provides Recommendations for Managing CDI in NICU

September 14, 2018 [Infectious Disease Special Edition] “Routine testing for Clostridioides difficile (formerly Clostridium difficile) should not be done in infants younger than 12 months of age who are in the neonatal ICU (NICU), according to new recommendations released by the Society for Healthcare Epidemiology of America.” Read full article here

Research Reveals Potential New Marker for Mortality Due to CDI

September 13th, 2018 [ContagionLive] Using serum eosinophil count can help predict patients who are at risk for poor C. diff infection outcomes. Read more here

How ‘Bad’ Bacteria Gain an Upper Hand in the Human Gut

September 11, 2018 [News Medical Life Sciences] A study conducted by researchers at the London School of Hygiene and Tropical Medicine revealed that C. diff bacteria produce a compound called para-cresol that promotes its survival by disrupting the growth of other intestinal microorganisms. Read full article here

Patients with Healthcare-Associated Infections Feel Like Lepers

September 11, 2018 [Evening Express] Many patients with healthcare-associated infections (HAIs) like MRSA have reported feeling “like a leper” or “dirty” after being diagnosed, according to a new study. Full article here 

share this post